Activity-based screening system for the discovery of neuraminidase inhibitors using protein chip technology

Biochip Journal

Volumn 6, Issue 2, 2012, Pages 133-138

  Park, Chan Won ^a   Kang, In Cheol ^a   Choi, Youngjin ^a  

^a Hoseo University   (South Korea)

Author keywords

Carbohydrate Protein interaction; Influenza virus; Neuraminidase inhibitor; ProteoChip ; Pseudomonas

Indexed keywords

BACTERIA; CARBOHYDRATES; FLUORESCENCE; RESPIRATORY SYSTEM; VIRUSES;

ACTIVITY-BASED; CARBOHYDRATE-PROTEIN INTERACTIONS; CHEMICAL LIBRARIES; CHIP SYSTEM; FLUORESCENCE INTENSITIES; FLUORESCENCE SIGNALS; GLYCOSIDIC LINKAGES; HOST ORGANISM; HUMAN BODIES; IN-VITRO; INFLUENZA VIRUS; INHIBITORY ACTIVITY; INHIBITORY COMPOUNDS; NEURAMINIDASE; PATHOGENIC INFECTIONS; PHARMACEUTICAL AGENTS; PROTEIN CHIP; PROTEIN CHIP TECHNOLOGY; PSEUDOMONAS; SCREENING SYSTEM;

PROTEINS;

FLUORESCENT DYE; I 13; I 14; I 18; I 21; I 27; I 39; I 45; LECTIN; OSELTAMIVIR; SIALIDASE; SIALIDASE INHIBITOR; SIALOPROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CATALYSIS; CELL SURFACE; DRUG ACTIVITY; DRUG DEVELOPMENT; DRUG SCREENING; FLUORESCENCE; HOST PATHOGEN INTERACTION; IN VITRO STUDY; MOLECULAR LIBRARY; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN MICROARRAY; PROTEIN SECRETION; VIRUS STRAIN;

EID: 84862537704     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-012-6205-5     Document Type: Article

References (18)

1. Soong, G. et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 116, 2297-2305 (2006).
2. Du, Q. S., Wei, H., Huang, R. B. & Chou, K. C. Progress in structure-based drug design against influenza A virus. Exp. Opin. Drug. Discov. 6, 619-631 (2011).
3. Colman, P. M., Hoyne, P. A. & Lawrence, M. C. Sequence and structure alignment of Paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J. Virol. 67, 2972-2980 (1993).
4. Galen, J. E. et al. Role of Vibrio cholera neuraminidase in the function of cholera toxin. Infect. Immun. 60, 406-415 (1992).
5. von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug. Discov. 6, 967-974 (2007).
6. Gubareva, L. V., Kaiser, L. & Hayden, F. G. Influenza virus neuraminidase inhibitors. Lancet355, 827-835 (2000).
7. Li, W. et al. Identification of GS4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitors GS4071. Antimicrob. Ag. Chemother. 42, 647-653 (1998).
8. Hayden, F. G. et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group. N. Engl. J. Med. 337, 874-880 (1997).
9. Marquis, S. M., Stanton, B. A. & O'Toole, G. A. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulmon. Pharmacol. Therapeu. 21, 595-599 (2008).
10. Galen, J. E. et al. Role of Vibrio cholera neuraminidase in the function of cholera toxin. Infect. Immun. 60, 406-415 (1992).
11. Godoy, V. G., Dallas, M. M., Russo, T. A. & Malamy, M. H. A role for Bacteroides fragilis neuraminidase in bacterial growth in two model systems. Infect. Immun. 61, 4415-4426 (1993).
12. Bouchet, V. et al. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. U. S. A. 100, 8898-8903 (2003).
13. Vimr, E. R., Kalivoda, K. A., Deszo, E. L. & Steenbergen, S. M. Diversity of microbial sialic acid metabolism. Microbiol. Mol. Biol. Rev. 68, 132-153 (2004).
14. Leprat, R. & Michel-Briand, Y. Extracellular neuraminidase production by a strain of Pseudomonas aeruginosa isolated from cystic fibrosis. Ann. Microbiol. 131B, 209-222 (1980).
15. Cacalano, G., Kays, M., Saiman, L. & Prince, A. Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J. Clin. Invest. 89, 1866-1874 (1992).
16. Chen, Y. J., Uttamchandani, M., Zhu, Q., Wang, G. & Yao, S. Q. Developing a strategy for activity-based detection of enzymes in a protein microarray. Chem. BioChem. 4, 336-339 (2003).
17. Bang, J. Y. et al. Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B), a Korean traditional medicine, using antibody microarray chip. BioChip J. 4, 350-355 (2010).
18. Russell, R. J. et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature443, 45-59 (2006).